Loews Corp Abb Vie Inc. Transaction History

Loews Corp

  • $12.6 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$138.31 - $165.87 $1.38 Million - $1.66 Million
10,000 Added 14.29%
80,000 $12.9 Million
Q3 2022

Nov 10, 2022
SELL
$134.21 - $153.93 $1.34 Million - $1.54 Million
-10,000 Reduced 12.5%
70,000 $9.4 Million
Q1 2022

May 11, 2022
SELL
$131.98 - $163.75 $11.9 Million - $14.7 Million
-90,000 Reduced 52.94%
80,000 $13 Million
Q4 2021

Feb 11, 2022
SELL
$107.43 - $135.93 $3.22 Million - $4.08 Million
-30,000 Reduced 15.0%
170,000 $23 Million
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $4.26 Million - $4.83 Million
40,000 Added 25.0%
200,000 $21.6 Million
Q2 2021

Aug 12, 2021
SELL
$105.21 - $117.21 $2.1 Million - $2.34 Million
-20,000 Reduced 11.11%
160,000 $18 Million
Q1 2021

May 14, 2021
SELL
$102.3 - $112.62 $1.53 Million - $1.69 Million
-15,000 Reduced 7.69%
180,000 $19.5 Million
Q4 2020

Feb 12, 2021
BUY
$80.49 - $108.67 $5.63 Million - $7.61 Million
70,000 Added 56.0%
195,000 $20.9 Million
Q3 2020

Nov 12, 2020
SELL
$85.91 - $100.83 $859,100 - $1.01 Million
-10,000 Reduced 7.41%
125,000 $10.9 Million
Q2 2020

Aug 13, 2020
SELL
$73.37 - $98.18 $1.1 Million - $1.47 Million
-15,000 Reduced 10.0%
135,000 $13.3 Million
Q1 2020

May 12, 2020
BUY
$64.5 - $97.79 $9.68 Million - $14.7 Million
150,000 New
150,000 $11.4 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Loews Corp Portfolio

Follow Loews Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loews Corp, based on Form 13F filings with the SEC.

News

Stay updated on Loews Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email